PATENT CLAIM ANALYSIS

Application Number: 15880801
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "729000"]

Abstract:
A cannabinoid-based pharmaceutical composition for the prevention and treatment of pathogenic viruses (particularly those causing hepatic related conditions such as hepatitis B and C), and most particularly for hepatitis C virus (HCV) infection, having a cannabidiol structure or a pharmaceutically acceptable salt thereof. A method for the prevention and treatment of pathogenic viruses (particularly those causing viral hepatic related conditions such as hepatitis B and C), and most particularly for HCV is also disclosed.

Claim (Index 1):
A method of treating a pathogenic virus in a human subject comprising periodically administering a therapeutically-effective dose of cannabidiol (CBD) to said subject.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.88889
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14722991', '15789998', '13162160', '15554209', '12141634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7422316076813286
- 35 USC 102 Novelty (BERT): 0.4796309380342957
- Combined Prediction Score: 0.7159715407166253
- Mean Citation Score: 212.47810400000003
- Max Citation Score: 216.57024
- Similarity Product: 176.57649103923802

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test